2nd Edition of International Cancer & Immuno-Oncology Conference
March 19-21, 2026 | Singapore
Radiotherapy
Radiotherapy, a cornerstone of cancer treatment, utilizes high-energy radiation to target and destroy cancerous cells. Its efficacy stems from its ability to damage the DNA within these cells, impeding their ability to proliferate. This treatment modality has evolved significantly, with advancements like intensity-modulated radiation therapy (IMRT) and stereotactic body radiation therapy (SBRT) offering more precise and targeted delivery, minimizing damage to surrounding healthy tissue.
Moreover, emerging techniques such as proton therapy hold promise in further enhancing treatment outcomes by precisely directing radiation to tumors while sparing adjacent organs. Despite its effectiveness, radiotherapy can induce side effects, including fatigue, skin irritation, and potential long-term complications. Continued research focuses on refining radiotherapy protocols, exploring combination therapies, and developing novel radiation delivery systems to improve patient outcomes and quality of life in the fight against cancer.
Rajvir Dahiya
University of California San Francisco, United States
Atif A Ahmed
University of Washington-Seattle Children’s Hospital, United States
Anyou Wang
DIFIBER LLC, United States
Paulo Cesar De Morais
Catholic University of Brasilia, Brazil
Allen Chen
Olympic Medical Center, United States
Shilpa S Dhar
UT MD Anderson Cancer Center, United States
Ritu Khanna
University of Manchester, United KingdomSubmit your abstract Today
Title : A novel blood-based mRNA genomics technology for cancer diagnosis and treatment
Rajvir Dahiya, University of California San Francisco, United States
Title : tRNA-derived fragment 3′tRF-AlaAGC modulates cell chemoresistance and M2 macrophage polarization via binding to TRADD in breast cancer
Feng Yan, The Affiliated Cancer Hospital of Nanjing Medical University, China
Title : Integrating single-cell and spatial transcriptomics to uncover and elucidate GP73-mediated pro-angiogenic regulatory networks in hepatocellular carcinoma
Jiazhou Ye, Guangxi Medical University Cancer Hospital, China
Title : Unveiling the synergism of radiofrequency therapy and graphene nanocomposite in tumor cell viability assay
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Analysis of the dynamic evolution and influencing factors of nutritional risk in breast cancer patients during treatment
Jingwen Yan, Sun Yat-sen University, China
Title : Integrative multi-omics reveals metabolic–stemness coupling and novel therapeutic targets in osteosarcoma chemoresistance
Jinyan Feng, Tianjin Medical University Cancer Institute and Hospital, China